Back to Search Start Over

Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies.

Authors :
Hammond-Thelin LA
Thomas MB
Iwasaki M
Abbruzzese JL
Lassere Y
Meyers CA
Hoff P
de Bono J
Norris J
Matsushita H
Mita A
Rowinsky EK
Source :
Investigational New Drugs; Feb2012, Vol. 30 Issue 1, p316-326, 11p
Publication Year :
2012

Details

Language :
English
ISSN :
01676997
Volume :
30
Issue :
1
Database :
Complementary Index
Journal :
Investigational New Drugs
Publication Type :
Academic Journal
Accession number :
104627943